Accuray, Inc. (ARAY) Acquires TomoTherapy, Inc. (TOMO) to Boost Industry Offerings and Opportunity

QualityStocks would like to highlight Accuray Incorporated (NASDAQ: ARAY), based in Sunnyvale, Calif., a global leader in the field of radiosurgery. The company is dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas.

In the company’s news yesterday,

Accuray announced it has completed its acquisition of TomoTherapy, Inc. to create a premier radiation oncology company with best-in-class technologies to fight cancer.

The combined company will focus on the development, manufacturing and selling of personalized, leading-edge treatment solutions, including high-precision radiosurgery and image-guided, intensity modulated radiation therapy.

“The successful closing of this transaction is a significant accomplishment and an important milestone in Accuray’s history. Scale is important in the capital equipment industry, and today Accuray’s installed base more than doubles, generating greater opportunity for service revenue and for replacement business over time to customers who have purchased these best-in-class technologies,” Euan S. Thomson, Ph.D., president and CEO of Accuray stated in the press release.

Accuray said that by integrating the expertise and complementary resources of both companies, Accuray is positioned to grow and invest in the R&D that will keep it on the leading edge of innovation.

Derek Bertocci, senior vice president and CFO of Accuray, said the acquisition will equip Accuray with a more predictable revenue channel and assist the TomoTherapy with becoming more efficient and ultimately profitable.

The transaction also nearly doubles Accuray’s installed base to more than 500 systems in 32 countries, and doubles employees to more than 1,000 worldwide. While corporate headquarters will remain in Sunnyvale, Calif., the newly created company will maintain a presence in Madison, Wis., where TomoTherapy’s headquarters were located.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.